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Abstract
Aims—To identify demographic, family and clinical characteristics associated with provider 
recommended frequency of blood glucose monitoring (BGM), actual frequency of BGM, and 
concordance between these categories in youth with type 1 diabetes (T1D) as reported by child’s 
caregiver.
Methods—Caregivers of 390 children 10–17 years were interviewed about their children’s 
providers’ recommendations for frequency of BGM and their child’s frequency of performance of 
BGM.
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Results—The majority (92%) of caregivers reported being told that their child should BGM ≥4 
times per day and 78% reported their child checked that frequently. Caregivers of children who 
were younger, non-Hispanic White, from two-parent households, higher income households, and 
on insulin pumps were more likely to report being told by their provider to perform BGM ≥6 times 
per day and more likely to report that their child performed BGM ≥6 times per day. Younger 
children and those with private health insurance were more likely to adhere to reported 
recommendations. Children whose caregivers reported that their child met/exceeded their provider 
recommendations had lower A1c values than those who did not.
Conclusions—These findings may help clinicians identify subgroups of youth at-risk for poor 
diabetes management and provide further education in order to improve outcomes.
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Introduction
Given the complexity and demanding nature of modern-day treatment regimens for type 1 
diabetes, it is not surprising that reported adherence to treatment recommendations among 
youth with diabetes is low, particularly among adolescents [1, 2]. Understanding the factors 
that are related to adherence is critical. Studies have clearly demonstrated that persons with 
higher levels of adherence to their treatment regimens have better glycemic control [3, 4]. 
Since sub-optimal glycemic control is associated with an increased risk for the development 
of diabetes-related complications [5], youth with T1D should strive to achieve and maintain 
good glycemic control, even at an early age. However, optimal glycemic control in youth is 
not often achieved, particularly by older youth [6, 7].
Based on the findings of the Diabetes Control and Complications Trial [8], frequent blood 
glucose monitoring (BGM) has become a cornerstone of optimal diabetes management. 
Adherence to frequent BGM has been found to be an integral factor in achieving optimal 
glycemic control [1, 9]. Greater BGM has been reported to be associated with younger age 
and insulin pump use [9, 10]. In most cases, a linear increase in BGM per day resulted in 
improvements in glycated hemoglobin (A1c) [1], but recent analyses have suggested that 
this effect may peak at five times per day [10].
While previous research has shown that BGM is an important contributor to glycemic 
control, little is known about whether BGM by children with type 1 diabetes corresponds 
with the frequency of BGM recommended by their health care providers. Using data from 
the SEARCH for Diabetes Study, these analyses explore demographic, family and clinical 
characteristics associated with provider recommended frequency of BGM, actual frequency 
of BGM, and concordance between these categories in children with T1D as reported by 
child’s caregiver. Additionally we explore the associations between recommended and 
reported frequency of BGM and A1c measurements.
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SEARCH for Diabetes in Youth is a multicenter study that conducts population-based 
ascertainment of youth with clinically diagnosed, non-gestational diabetes who are <20 at 
the time of diagnosis [11]. SEARCH has enrolled youth newly diagnosed with diabetes from 
2002 through the present. Cases are ascertained from geographically defined populations in 
Ohio, Colorado, South Carolina and Washington, Indian Health Service beneficiaries from 
four American Indian populations, and enrollees in several health plans in California and 
Hawaii. Youth whose diabetes is not secondary to other conditions are invited to a SEARCH 
study visit. After obtaining informed consent and assent, physical measurements and fasting 
blood samples are collected from metabolically stable children, and questionnaires are 
administered. Youth whose diabetes was incident in 2002 through 2005 and who completed 
a baseline study visit were invited to return for follow-up visits.
The data included in this analysis are from children with T1D who were 10 through 17 years 
of age and their parent/guardian (“caregivers”) who accompanied them at their 24-month 
SEARCH follow-up visit where questions about their child’s provider recommendation for 
frequency of BGM and their child’s actual frequency of BGM were asked. The response rate 
for this follow-up visit was 52%. Of the 390 participants who completed a follow-up visit, 
94% (n=385) completed the survey which included the questions about BGM.
Measures
Demographic variables included age at study visit, sex, race/ethnicity, and insurance status. 
Insurance was categorized as private, state-funded (Medicaid/Medicare, etc), other (which 
included student health clinics, military, Indian Health Services), or none. Family variables 
included family income which was categorized as <$25K, $25–49K, $50–74K, $75K+, 
don’t know/refused, and family composition which was categorized as 2-parent household, 
1-parent household, or other/unknown composition.
Clinical variables included duration of diabetes since diagnosis, insulin regimen, 
depression, and glycemic control. Duration of diabetes was the length of time between date 
of diagnosis and the 24-month visit. Insulin regimen was categorized as 1) basal-bolus using 
the insulin pump, 2) basal-bolus with glargine plus rapid-acting insulin, 3) multiple daily 
injections (MDI) with ≥3 injections/day, using glargine plus more than/or other than rapid-
acting insulin type, 4) MDI with ≥3 injections/day, using any insulin types excluding basal 
insulin, or 5) 1 to 2 injections/day, excluding glargine [6]. Detemir and glulisine were not in 
clinical use during the data collection period. Depression was assessed based on the child’s 
responses on the Center for Epidemiologic Studies Depression scale (CES-D) [12]. This 20-
item scale is a commonly used measure of depressive symptomatology in children age 10 
years and older [13, 14]. For these analyses, we categorized the scores as minimally (0–15), 
mildly (16–23), and moderately/severely (24–60) depressed mood [15, 16].
Glycemic control was assessed using blood samples shipped to a central laboratory 
(Northwest Lipid Research Laboratories, Seattle, WA) for analysis. An ion exchange unit 
(Variant II; Bio-Rad Diagnostics, Hercules, CA) quantified the glycated hemoglobin (A1c) 
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levels. Optimal age-specific goals for A1c in children are <8.0% for 10–12 year olds, and 
<7.5% for 13–18 year olds [17].
BGM Recommendations, Behaviors, and Adherence—Caregivers of children with 
T1D were asked to report the frequency of BGM recommended by their child’s health care 
provider and the number of times per day their child conducted BGM over the last 3 months. 
Response options for both questions were 6 or more times daily, 4–5 times daily, 2–3 times 
daily, at least once daily, or don’t know. Adherence to recommendations was determined by 
comparing their responses to questions about recommended and actual BGM frequency, and 
categorized as exceeded (child monitored more than recommended by provider), met (child 
monitored exactly as the provider recommended), or did not meet (child monitored less than 
what the provider recommended) their child’s provider recommendation for daily BGM.
Statistical Analysis
Analyses were conducted using SAS version 9.2 (SAS Institute, Cary, North Carolina). 
Descriptive statistics (means, standard deviations, frequencies, and percents) were used to 
summarize demographic, family, and clinical variables. Chi-square tests were used to assess 
the associations between categorical variables. Unadjusted associations between 
demographic, clinical, and family characteristics and age, receipt of BGM 
recommendations, adherence to provider BGM recommendations, and A1c values measured 
at the study visit were assessed using chi-square tests, analysis of variance (ANOVA), or 
Kruskal-Wallis tests. Multivariable linear regression was used to assess the association 
between A1c levels with BGM recommendations and reported behaviors, adjusted for age 
and insulin regimen. Logistic regression was used to determine which variables were 
independently predictive of meeting or exceeding provider recommendations. Variables 
used in the logistic model included site, age (10–12, 13–15, 16+), gender, race (non-
Hispanic White [NHW] versus other), insurance (private versus other), income, family 
composition (2 parent household versus other), diabetes duration (≤ 3 years, > 3 years), 
insulin regimen, and depressive symptoms. Results were considered significant if p < 0.05.
Results
Table 1 shows the demographic, family and clinical composition of the 390 eligible children 
with T1D. They ranged from ages 10–17 (mean ± SD = 14.0±2.3 years) with a mean 
diabetes duration of just over 3 years (37.4 months). About half were female (48%) and 74% 
were NHW. Youth 13–15 years had the highest mean A1c values (9.2±1.9 for 13–15 year 
olds, 8.4±1.5 for 10–12 year olds, and 8.7±1.8 for 16–17 year olds; p=.003) and were least 
likely to be in adequate control based on their A1c value (15% of 13–15 year olds, 41% of 
10–12 year olds, and 27% 16+ met the goal; p < .001). Other demographic, clinical, and 
family characteristics did not differ significantly by age (data not shown).
Reported recommendation for BGM frequency
Of the caregivers surveyed, 22% reported that they were told by their health care provider 
their child should conduct BGM at least 6 times/day, 69% reported 4–5 times/day, and 8% 
reported 2–3 times/day (Table 2, n=5 with missing data). There was a significant difference 
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in recommended frequency by study centers (p=.04, data not shown). Caregivers report of 
recommended frequency of BGM varied significantly by their child’s age, race/ethnicity, 
household composition and family income as well as insulin regimen and glycemic control 
(Table 2). Younger, NHW participants, those from two parent households, those from 
families with higher incomes, and those on an insulin pump were significantly more likely to 
report being told to conduct BGM at least 6 times/day (Table 2). Additionally, caregivers of 
children who met their A1c goal were more likely to report being told to check more 
frequently than those who did not meet their goal. The child’s gender, health insurance 
status, duration of diabetes and depression scores were not associated with caregivers’ report 
of providers’ recommendations.
Reported BGM behavior
Of the caregivers surveyed, 26% reported that their child conducted BGM at least 6 times/
day, 52% 4–5 times/day, 16% 2–3 times/day, and 6% reported fewer than 2 times/day 
(Table 2, n=2 with missing data). There was no significant difference between participant 
responses by study center (data not shown). Caregivers of younger children, those from two 
parent households, those with higher incomes, those who were NHW, and those on an 
insulin pump were more likely to report that their child conducted BGM at least 6 times/day 
(Table 2). Additionally, those children who met their A1c goal were more likely to have 
caregivers who reported that they conduct BGM more frequently than those who did not 
meet their goal. There was no association between frequency of BGM and child’s gender, 
health insurance status, duration of diabetes, or depressive symptoms.
Associations of reported BGM recommendations and behaviors with A1c
A1c was significantly lower for children whose caregivers reported that providers 
recommended BGM at least 6 times per day compared to those who reported that their 
providers recommended BGM 4–5 times per day, or fewer. A1c values were also 
significantly lower for children who reported that providers recommended BGM 4–5 times 
per day compared to those who reported that their providers recommended BGM less than 4 
times per day. Adjustment for age and insulin regimen did not change these results (Table 3, 
top).
A1c also varied significantly by the number of times caregivers reported that BGM was 
conducted (Table 3, bottom, p<.001). Youth with caregivers who reported their child 
conducted BGM at least 6 times a day had significantly lower A1c values than those who 
reported BGM fewer than 6 times a day; those who performed BGM 4–5 times a day had 
significantly lower A1c values than those who conducted BGM fewer than 4 times a day. 
Adjustment for age and insulin regimen did not change these results (Table 3).
Associations with adherence to provider BGM recommendations
We then compared caregivers’ report of provider recommendations for BGM to their report 
of their child’s frequency of BGM. While most of the caregivers (92%) reported being told 
by their children’s providers to conduct BGM at least 4 times /day (4–5 times or 6+ times/
day), only 78% reported checking that frequently. Table 4 shows that adherence to 
recommended monitoring frequency was reported by 62% of the caregivers, with 24% 
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reporting they test less frequently than recommended and 14% reporting they test more 
frequently. Of 10–12 year olds, 92% met or exceeded provider recommendations versus 
72% of 13–15 year olds and 61% of ≥16 year olds (p<.001). Those with private insurance 
reported meeting or exceeding provider recommendations more than those without (79% 
versus 65%, p=.01), and those who met A1c goal reported meeting or exceeding provider 
recommendations more than those who did not (91% versus 68%, p=.001).
In the adjusted analysis using multivariable logistic models, age (odds ratio [OR] = 8.6, 95% 
confidence interval [CI]=3.8 – 19.6 for 10–12 year olds and OR=1.4 (CI=0.8 – 2.5) for 13–
15 year olds, relative to ≥16 year olds), private insurance (OR = 2.8, CI: 1.3 – 6.2), and A1c 
(Exceeded = 8.6±1.4, Met = 8.5±1.6, Did not meet = 9.7±1.9; p < .001) predicted meeting or 
exceeding provider recommendations. Gender, family income, household composition, 
duration of diabetes, insulin regimen or depression scores were not significantly associated 
with reported adherence to recommended monitoring frequency.
Discussion
These findings demonstrate that, among a large diverse sample of children with T1D, most 
caregivers (92%) reported being told by their child’s health care provider to conduct BGM 
at least 4 times per day. However, only 78% reported that their child monitored that often. 
Children whose caregivers reported that they monitored more frequently had lower A1c 
values. Although causality cannot be determined from these cross-sectional data, previous 
reports have shown the detrimental effect of poor adherence to BGM monitoring 
recommendations on A1c [3]. Specifically, increased adherence has been associated with 
lower A1c [1, 9]. Thus, our results reinforce the notion that BGM is strongly associated with 
glycemic control in children with T1D.
One previous study reported that increasing BGM frequency to greater than 5 times a day 
did not result in further improvement of A1c [10]. In contrast, our findings suggest that 
those who reported checking at least 6 times per day did better than those who checked 4–5 
times per day or less. Given this finding, it is interesting that only 22% of caregivers 
reported their provider recommended to check BGM 6 or more times per day. While 
frequency of provider recommendations did vary across study sites, no site differences were 
found in reported behaviors. In fact, compared to the percentage of caregivers reporting their 
provider recommended BGM ≥6 times per day, a slightly larger percentage of caregivers 
(26%) reported their child actually monitored that often. More attention to the accuracy of 
the “topping out” factor cited by Ziegler et al.’s study and factors that may be involved in 
checking more than prescribed would be valuable, and may also have insurance policy 
coverage implications for BGM supplies [10].
Age, race/ethnicity, and family variables including income and household structure emerged 
as important factors associated with reported recommendations for BGM, frequency of 
BGM, and adherence to provider recommendations. Differences in age were particularly 
noteworthy as there was a significant difference in reported adherence to provider 
recommendations between the youngest and oldest children: only 60% of 16–17 year olds 
met or exceeded provider recommendations for BGM, compared with 93% of 10–12 year 
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olds. These results are consistent with other studies which have demonstrated that older 
children with diabetes have poorer adherence to diabetes treatment than younger children 
[18, 19].
We also found that NHW participants reported being told to BGM more frequently than 
other race categories. While this study is not able to determine whether this is based on 
caregivers’ perceptions or actual provider behavior, this finding may support growing 
literature showing racial disparities in diabetes outcomes [20], and specifically corroborates 
reports indicating a disparity in regimen intensity for minority youth with type 1 diabetes 
[21]. In addition, those on an insulin pump were more likely to report more frequent 
monitoring. This supports the findings of Cortina et al. [22], who also found that insulin 
pump users reported higher BGM than those on multiple daily injection regimens. Clearly 
there is a need to better understand the clinical implications, potential selection bias, and 
disparities that may exist surrounding intensity of the BGM recommendations children 
receive as well as their adherence behaviors.
There were several limitations to this study. Causality cannot be established from cross-
sectional analyses. Participation in the follow-up visit was sub-optimal, which may 
compromise the generalizability of these findings; for example, previous findings from the 
SEARCH study found that older children were less likely to participate in SEARCH study 
visits than younger children [23]. However, of the participants, response rate to the survey 
was high (94%). Further, the provider recommendations assessed and the actual frequency 
of BGM were both based on the report from the children’s caregiver which was the parent or 
guardian who accompanied them to the study visit. We do not have their health care 
providers’ report of their actual recommendations nor a confirmation of the actual frequency 
of BGM from either the children with diabetes or from downloading their meter as these 
measures were not collected as part of the study protocol. We therefore cannot be sure 
whether these reports, particularly those for the frequency of BGM, may accurately reflect 
their actual frequency of BGM, particularly among older teens who are more likely to be 
responsible for their own care. However, caregivers’ recall or understanding of these 
recommendations, in particular, may be as important as what was actually recommended. It 
is reassuring to know that most caregivers report that health care providers recommended 
BGM at least 4 times per day. It is acknowledged that the caregiver report of actual BGM 
frequency may be overestimated. However, given the discordance reported between the 
provider recommendations and actual BGM frequency and the significant associations found 
with A1c, we can be somewhat confident that these results, if inaccurate, may actually be 
conservative. Strengths of the study include sample size and the ethnic and geographic 
diversity of the children in the SEARCH study. In addition, measurement of A1c was 
consistent across centers and over time through the use of a single laboratory.
The need for age-specific interventions which focus on improving diabetes self-management 
is well-established [24, 25]. Understanding the demographic and clinical characteristics of 
children associated with adherence to BGM may elucidate the groups most at-risk for poor 
management and subsequent poor outcomes later in life. Targeting interventions to groups 
identified in this study who reported not knowing, or not following, these recommendations 
may be useful for clinicians aiming at improving glycemic outcomes in children with T1D.
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Table 1




Age at Study Visit (years)
 10–12 136 (35)
 13–15 161 (41)
 16–17 93 (24)
Gender
 Female 189 (48)
 Male 201 (52)
Race/Ethnicity
 Black 40 (10)
 Hispanic 45 (12)
 Non-Hispanic White 289 (74)
 Other 16 (4)
Health Insurance
 Private 307 (79)
 Medicaid/Medicare 70 (18)
 Other 8 (2)
 None 5 (1)
Family Variables
Family Income
 <25K 56 (14)
 25–49K 61 (16)
 50–74K 81 (21)
 75K+ 171 (44)
 Don’t know or Refused 21 (5)
Family Composition
 2 parent household 273 (70)
 1 parent household 102 (26)
 other/unknown 15 (4)
Clinical Variables
Duration of Diabetes (months) – Mean ± SD 37.4±7.5
 ≤3 years 195 (50)
 >3 years 195 (50)
Insulin Regimena
 1 153 (40)
 2 133 (34)
 3 42 (11)
 4 33 (9)













Yi-Frazier et al. Page 11
N (%)
 5 25 (6)
HbA1c (%) – Mean (SD) 8.8±1.8
HbA1c Goalb
 Met 93 (27)
 Not Met 253 (73)
CES-Dc Score Category
 Minimally (<16) 317 (83)
 Mildly (16–23) 49 (13)
 Moderately/Severely (≥ 24) 17 (4)
a
Insulin regimen categories: 1) insulin pump, 2) long + short/rapid insulin, 3) 3X+/day long + any other combination, 4) 2X+/day any insulin 
combination excluding long, 5) 3X+/day any insulin(s) taken 1x/day, or any insulin combination excluding long 2x/day.
b
Met = <8.0% for 10–12 year olds and <7.5% for 13–17 year olds
c
CES-D= Center for Epidemiologic Studies of Depression
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Table 3
Associations between reported frequency of blood glucose monitoring per day and A1c values.
How many blood glucose checks/day provider suggested
Unadjusted Adjusted for Age and Insulin Regimen
N Mean A1c ± SE N Mean A1c ± SE
≥6/day 78 8.34 ± 0.18 a 77 8.42 ± 0.20 a
4–5/day 235 8.87 ± 0.11 234 8.85 ± 0.11
<4/day 28 9.98 ± 0.35 28 9.76 ± 0.32
p-value for trend <.001 .002
How many blood glucose checks/day reported N Mean A1c ± SE N Mean A1c ± SE
≥6/day 91 8.04 ± 0.14b,c,d 90 8.07 ± 0.19b,c,d
4–5/day 172 8.76 ± 0.12c 172 8.71 ± 0.12c
2–3/day 60 9.88 ± 0.25 60 9.80 ± 0.21
<2/day 21 9.53 ± 0.45 20 9.51 ± 0.36
p-value for trend <.001 <.001
a
all groups significantly different from one another
b
significantly different from 4–5/day
c
significantly different from 2–3/day
d
significantly different from <2/day
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Table 4
Caregivers report of blood glucose monitoring frequency relative to their report of providers’ 
recommendations for blood glucose monitoringa
Provider Recommendation for BGM BGM Frequency in Relation to Provider Recommendation – n (%)a
Frequency of BGM N (%)b Exceeded Met Did Not Meet
≥ 6 times/day 86 (22) --- 60 (70) 26 (30)
4–5 times/day 267 (70) 41 (15) 167 (63) 59 (22)
<4 times/day 31 (8) 14 (45) 11 (35) 6 (19)






One participant was missing and was excluded from this analysis.
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